Balance Sheet for Stemline Therapeutics Inc. (STML)

$ 11.83 0.00 (0.00%) Volume: 0 4:00 PM EDT 10-Jun-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 13,562 9,444 4,795 10,316 13,376
Restrictable Cash - - - - -
Marketable Securities 150,869 50,662 46,925 36,563 32,663
Accounts Receivable 15,120 - 150 35 299
Loans Receivable - - - - -
Other Receivables 658 843 150 35 299
Receivables 15,778 843 150 35 299
Inventories, Raw Materials 49 - - - -
Inventories, Work in Progress 1,054 - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 1,453 - - - -
Inventories, Other 1,151 - - - -
Inventories, Adjustments & Allowances (1,405) - - - -
Inventories 1,151 - - - -
Prepaid Expenses 3,801 2,110 175 256 353
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 185,162 63,059 52,189 47,170 46,691
Land and Improvements - - - - -
Buildings and Improvement 83 83 83 - -
Machinery, Furniture and Equipment 738 675 533 487 479
Construction in Progress - - - - -
Fixed Assets, Other 1,318 - - - -
Fixed Assets, Total 2,138 758 615 487 479
Gross Fixed Assets 2,138 758 615 487 479
Accumulated Depreciation (629) (535) (479) (464) (384)
Net Fixed Assets 1,509 222 137 23 96
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 309 212 212 212 -
Total Non-Current Assets 1,818 435 14,817 20,949 51,524
Total Assets 186,979 63,494 67,006 68,119 98,216
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable - - - - -
Short Term Debt 1,170 - - - -
Notes Payable - - - - -
Accrued Expenses 16,353 15,638 16,802 7,309 5,905
Accrued Liabilities 16,353 15,638 16,802 7,309 5,905
Deferred Revenues - - - 898 823
Current Deferred Income Taxes - - - (25) -
Other Current Liabilities 5,609 5,581 3,037 2,046 2,728
Total Current Liabilities 23,132 21,219 19,839 10,254 9,455
Long Term Debt N/A N/A N/A - -
Deferred Income Tax - - - - 617
Other Non-Current Liabilities 4 73 97 142 648
Minority Interest - - - - -
Capital Lease Obligations 226 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 231 73 97 142 648
Total Liabilities 23,363 21,292 19,936 10,396 10,104
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 163,616 42,202 47,070 57,723 88,112
Common Par 5 3 3 2 2
Additional Paid in Capital 529,488 331,344 251,490 193,564 185,703
Cumulative Translation Adjustments - - - - -
Retained Earnings (365,905) (289,088) (204,276) (135,743) (97,440)
Treasury Stock - - - - -
Other Equity Adjustments 28 (57) (146) (100) (154)
Total Capitalization 163,616 42,202 47,070 57,723 88,112
Total Equity 163,616 42,202 47,070 57,723 88,112
Total Liabilities & Shareholder's Equity 186,979 63,494 67,006 68,119 98,216
Cash Flow (75,915) (84,984) (67,983) (38,604) (37,675)
Working Capital 162,030 41,840 32,350 36,916 37,236
Free Cash Flow (67,753) (72,295) (49,748) (30,100) (25,609)
Invested Capital 163,616 42,202 47,070 57,723 88,112
Shares Outstanding - Common Class Only 50,349 31,943 25,314 19,219 18,235
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 50,349 31,943 25,314 19,219 18,235
Total Common Shares Outstanding 50,349 31,943 25,314 19,219 18,235
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 42,091 28,389 23,057 17,805 17,289
Diluted Weighted Shares Outstanding 42,091 28,389 23,057 17,805 17,289